| Literature DB >> 17852026 |
Michael Y Shapira1, Ali Abdul Hai, Panagiotis Tsirigotis, Igor B Resnick, Reuven Or, Shimon Slavin.
Abstract
Allogeneic bone marrow or blood stem cell transplantation (SCT) has changed its face in the last two decades. The introduction of nonmyeloablative conditioning regimens has reduced procedure toxicity and allowed the application of SCT in patients and conditions in which SCT was not offered in the past. In this review we will summarize the changes and accomplishments achieved in the past years in the field of stem cell transplantation for malignant disorders.Entities:
Mesh：
Year: 2007 PMID： 17852026 DOI： 10.1080/07853890701472323
Source DB: PubMed Journal: Ann Med ISSN： 0785-3890 Impact factor: 4.709